high quality dbp agents dbp agents

  • high quality dbp agents dbp agents
  • high quality dbp agents dbp agents
  • high quality dbp agents dbp agents
  • Do disparate levels of SBP and DBP affect blood pressure staging?
  • When a disparity exists between SBP and DBP stages, patients are classified into the higher stage (“up-staged”). We evaluated the effect of disparate levels of SBP and DBP on blood pressure staging and eligibility for therapy.
  • What is the optimal DBP target?
  • Admittedly, the optimal DBP target of 70 to 79 mm Hg identified in our meta-analysis is higher than the DBP achieved in the intense treatment arm of SPRINT (68.7 mm Hg) and much higher than that achieved in the lowest DBP quintile in SPRINT (59 mm Hg).
  • Is a low DBP a risk factor?
  • It cannot be excluded that in untreated patients, a low DBP may be an index of a much higher risk than in SPRINT patients, whose low baseline DBP was the result of baseline antihypertensive therapy and in the absence of treatment was presumably much higher.
  • What is the difference between SBP and DBP?
  • There was an even more striking disparity in SBP and DBP levels among this subgroup (Figure 2 ): 94% had an elevated SBP, whereas only 33% had an elevated DBP. Fully two thirds of the subjects had a normal DBP despite being in a high-normal or hypertensive JNC-VI stage. Again, the JNC-VI stage reflected the effect of up-staging on the basis of SBP.
  • Does a low baseline DBP cause a higher cardiovascular risk profile?
  • The first important contribution of the new SPRINT analyses 1 is to support this suspicion by showing that the SPRINT patients with DBP in the lowest baseline quintile (and consequently with the lowest achieved DBP values) had a higher cardiovascular risk profile and a significantly greater hazard of the primary outcome than the other patients.
  • What is a good DBP level for a diabetic patient?
  • The European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) recommend targeting a DBP goal of <90 mmHg in the general population.5 A lower goal of <85 mmHg is recommended for patients with diabetes. However, the ESH/ESC guideline does not specify which drug class is preferred for treating elevated DBP.

Recommended hot-selling products